CMS
Natera Prospera Lung Test Receives Medicare Coverage for Single Lung Transplant Patients
The test was launched in 2022 and received coverage for double-lung transplant patients in 2023.
Exact Sciences Shares Rise on Unexpected Reimbursement Rate From CMS for Next-Gen Cologuard Test
The next-generation version of the Cologuard test received FDA approval last month and is expected to launch next year.
CMS Final Pricing for Genomic Procedure Codes Leaves Lab, Industry Stakeholders Wanting More
Premium
After going through the gapfill process and releasing final pricing for six codes related to genomic sequencing procedures, the final pricing still has stakeholders worried.
Adaptive Biotechnologies Test Receives Expanded Medicare Coverage for Mantle Cell Lymphoma
The firm's blood-based ClonoSeq test can be used to assess response to treatment, understand prognosis, and monitor patients to detect molecular recurrence.
Cofactor Genomics Immunotherapy Response Test Nabs Medicare Coverage
The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.
Aug 8, 2024
Local Coverage Determinations Roundup: Veracyte
May 1, 2024
Craig-Hallum Upgrades CareDx to Buy
Jan 3, 2024
Dec 6, 2023
Nov 6, 2023